Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
D000956:Antigens, Viral / Q000145:classification / Q000302:isolation & purification*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002051:Burkitt Lymphoma / Q000276:immunology; D002460:Cell Line; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology*; D007106:Immune Sera; D008214:Lymphocytes / Q000276:immunology; D009303:Nasopharyngeal Neoplasms / Q000276:immunology
D000956:Antigens, Viral; D007106:Immune Sera; D001973:Bromodeoxyuridine; D007065:Idoxuridine